TGFB1 and neoplasm: In addition, the DEGs of the two molecules were also associated with the transforming growth factor (TGF)-β signaling pathway, which impairs antitumor immune response such as antigen presentation and T cell infiltration in the tumor microenvironment, causing a limited response to ICIs [26,27].